Konstantinos Tsioufis, MD, PhD, FESC, FACC is an expert in Cardiology at Geniko Nosokomeio Athinon "Ippokrateio" (Greece). As of October 2026, ScienceLeadR ranks Konstantinos Tsioufis in the top 1% of experts worldwide for Hypertension, Coronary Disease and Arteriosclerosis. Konstantinos Tsioufis has authored 1,014 publications, the most recent in 2026, and is an investigator in 46 clinical trials, 14 of them ongoing. SLR score: 5,324 (community average: 125). How the SLR is computed.

LeadR Profile

Konstantinos Tsioufis, MD, PhD, FESC, FACC Geniko Nosokomeio Athinon "Ippokrateio" Greece
5 324 ScienceLeadR Reputation 5324
Network Map

Cardiology

Subspecialties: Biochemistry - Public Health - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026

Source: PubMed

National and Kapodistrian University of Athens

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1014

Citations

Citations: 32 381 1st author: 62 Last author: 367 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Machine Learning-Based Classification of Right and Left Ventricular Outflow Tract Premature Ventricular Contractions.
PMID 42934986 — ventricular premature complexes, classification, machine learning, catheter ablation, learning, catheters, electrocardiography
Ann Noninvasive Electrocardiol20260
Survival Outcomes in Transthyretin Cardiac Amyloidosis in the Tafamidis Era: Real-World Evidence from Greece.
PMID 42938212 — prealbumin, amyloidosis, diagnosis, transthyretin amyloid cardiomyopathy, transthyretin cardiac amyloidosis
Diagnostics (Basel)20260
Sex-Based Differences in Cognitive Performance in Patients with Cardiovascular Diseases.
PMID 42939278 — depression, cardiovascular diseases, cognitive dysfunction, sex, risk factors, menopause, geriatrics
Brain Sci20260
Non-Invasive Assessment of Coronary Microvascular Dysfunction: From Flow Quantification to Clinical Decision Making.
PMID 42942485 — research design, blood, clinical decision-making, tomography, positron-emission tomography, stress, physiological, decision making, echocardiography
Medicina (Kaunas)20260
Heart failure with supranormal ejection fraction: is it the new Ariadne's string?
PMID 42928386 — exercise, heart valve diseases, heart diseases, heart failure, heart, phenotype, therapeutics
Heart Fail Rev20260

Clinical Studies 46

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 8

By phase:

N/A 24
Phase 3 18
Phase 2 2
Phase 4 2

By status:

Completed 23
Recruiting 14
Unknown 6
Terminated 2
Not yet recruiting 1

By type:

Interventional 37
Observational 9

By Monocentric/Multicentric:

monocentric 18
multicentric2to4 6
multicentric5to9 3
multicentricup10 19

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

14 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
202301CPC Redefine HF
2023-508581-15-00 — mortality, safety, heart failure, heart, morbidity
Phase 3Recruiting2024
EASi PROTKT A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes high blood pressure and cardiovascular disease
2025-521188-11-00 — diabetes mellitus, hypertension, safety, blood, cardiovascular diseases, blood pressure, diabetes mellitus, type 2
Phase 3Recruiting2025
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME CV)
2024-516652-18-00 — cardiovascular diseases, obesity, therapeutics, overweight
Phase 3Recruiting2025
A Trial to Test How AZD0780 Affects Serious Heart Stroke or Vascular Problems in Patients with Heart Stroke or Vascular Disease or at High Risk for Such Issues
2025-520519-14-00 — stroke, heart, cardiovascular diseases, vascular diseases
Phase 3Recruiting2025
Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis
NCT07052071 — constriction, pathologic, aortic valve stenosis, aortic valve, transcatheter aortic valve replacement, gastrointestinal microbiome, microbiota, catheters
N/ARecruiting2025

LeadR Networks

Main global connection map